Natural history of indolent-anti-synthetase syndrome-associated interstitial lung disease
- 30 July 2024
- journal article
- research article
- Published by Elsevier in Respiratory Investigation
- Vol. 62 (5) , 872-878
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung diseaseClinical Rheumatology, 2023
- Role of serum surfactant protein-D as a prognostic predictor in fibrotic hypersensitivity pneumonitisRespiratory Investigation, 2022
- 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue diseaseRespiratory Investigation, 2021
- Clinical, radiological, and pathological features of anti-asparaginyl tRNA synthetase antibody-related interstitial lung diseaseRespiratory Investigation, 2020
- Predictive factors for the recurrence of anti-aminoacyl-tRNA synthetase antibody-associated interstitial lung diseaseRespiratory Investigation, 2020
- Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severityBest Practice & Research Clinical Rheumatology, 2018
- The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodiesRespiratory Medicine, 2017
- Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional studyClinical Rheumatology, 2016
- Pulmonary manifestations of anti-ARS antibody positive interstitial pneumonia – With or without PM/DMRespiratory Medicine, 2013
- Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumoniasRespiratory Medicine, 2011